WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Ownership - Who owns Seres Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Seres Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas DesrosierChief Legal Officer and EVP2024-02-163,939$1.08
$4.25kSell
Matthew R. HennChief Scientific Officer and EVP2024-02-164,170$1.08
$4.50kSell
Teresa L. YoungEVP Chief Commercial Strategy Officer2024-02-163,374$1.08
$3.64kSell
Eric D. ShaffCEO and President2024-02-1611,549$1.08
$12.47kSell
David ArkowitzChief Financial Officer2024-02-163,939$1.08
$4.25kSell
Moltke Lisa VonExecutive Vice President and Chief Medical Officer2024-02-164,400$1.08
$4.75kSell
David S. EgeExecutive Vice President and Chief Technology Officer2024-02-165,010$1.08
$5.41kSell
Teresa L. YoungEVP Chief Commercial Strategy Officer2023-10-302,907$1.35
$3.92kSell
Matthew R. HennChief Scientific Officer and EVP2023-10-303,886$1.35
$5.25kSell
Paula CloghessyExecutive Vice President Chief People Officer2023-10-302,904$1.35
$3.92kSell

1 of 2

MCRB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MCRB insiders and whales buy or sell their stock.

MCRB Shareholders

What type of owners hold Seres Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Nutritional Health Ltp Fund General Partner LLC15.81%23,869,081$15.63MInsider
Flagship Pioneering Inc15.31%23,117,045$15.14MInstitution
Fmr LLC12.84%19,388,580$12.70MInstitution
Blackrock Inc4.86%7,339,454$4.81MInstitution
Nestle Health Science Us Holdings Inc4.56%6,888,888$4.51MInsider
Vanguard Group Inc3.98%6,005,307$3.93MInstitution
Flagship Pioneering Fund Vii General Partner LLC3.86%5,825,495$3.82MInsider
Flagship Pioneering Inc2.94%4,444,444$2.91MInsider
Hudson Bay Capital Management LP2.86%4,320,400$2.83MInstitution
Noubar Afeyan1.82%2,750,135$1.80MInsider

1 of 3

MCRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MCRB59.28%30.14%Net SellingNet Selling
MIST33.44%24.16%
ELTX3.25%92.54%Net Buying
CNTB12.93%0.00%
ALLK46.03%53.97%Net SellingNet Selling
View Top Biotech Stocks

Seres Therapeutics Stock Ownership FAQ

Who owns Seres Therapeutics?

Seres Therapeutics (NASDAQ: MCRB) is owned by 59.28% institutional shareholders, 30.14% Seres Therapeutics insiders, and 10.58% retail investors. Nutritional Health Ltp Fund General Partner LLC is the largest individual Seres Therapeutics shareholder, owning 23.87M shares representing 15.81% of the company. Nutritional Health Ltp Fund General Partner LLC's Seres Therapeutics shares are currently valued at $14.75M.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.